Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1193902

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1193902

Alpha Emitters

PUBLISHED:
PAGES: 179 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 14850

Add to Cart

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Alpha Emitters Market to Reach $2.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Alpha Emitters estimated at US$561 Million in the year 2022, is projected to reach a revised size of US$2.6 Billion by 2030, growing at a CAGR of 21% over the analysis period 2022-2030. Bone Metastasis, one of the segments analyzed in the report, is projected to record a 20.5% CAGR and reach US$898.4 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Ovarian Cancer segment is readjusted to a revised 22.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $164.1 Million, While China is Forecast to Grow at 19.7% CAGR

The Alpha Emitters market in the U.S. is estimated at US$164.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$426.9 Million by the year 2030 trailing a CAGR of 19.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 19.1% and 18.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 15.2% CAGR.

Select Competitors (Total 12 Featured):

  • Actinium Pharmaceuticals, Inc.
  • Alpha Tau Medical
  • Bayer AG
  • Fusion Pharma
  • IBA Group
  • IBA Radiopharma Solutions
  • Lantheus Medical Imaging, Inc.
  • NTP Radiosotopes SOC Ltd.
  • RadioMedix, Inc.
  • Siemens Healthineers
  • Telix Pharmaceuticals Ltd.
  • Triad Isotopes, Inc.
Product Code: MCP10244

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Alpha Emitters - Global Key Competitors Percentage Market Share in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Alpha Emitters Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Alpha Emitters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 3: World 8-Year Perspective for Alpha Emitters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Bone Metastasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World 8-Year Perspective for Bone Metastasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Ovarian Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 7: World 8-Year Perspective for Ovarian Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pancreatic Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 9: World 8-Year Perspective for Pancreatic Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Melanoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World 8-Year Perspective for Melanoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 13: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Alpha Emitters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Alpha Emitters by Application - Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 15: USA 8-Year Perspective for Alpha Emitters by Application - Percentage Breakdown of Value Sales for Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications for the Years 2023 & 2030
  • CANADA
    • TABLE 16: Canada Recent Past, Current & Future Analysis for Alpha Emitters by Application - Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 17: Canada 8-Year Perspective for Alpha Emitters by Application - Percentage Breakdown of Value Sales for Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications for the Years 2023 & 2030
  • JAPAN
    • Alpha Emitters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 18: Japan Recent Past, Current & Future Analysis for Alpha Emitters by Application - Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 19: Japan 8-Year Perspective for Alpha Emitters by Application - Percentage Breakdown of Value Sales for Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications for the Years 2023 & 2030
  • CHINA
    • Alpha Emitters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Alpha Emitters by Application - Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 21: China 8-Year Perspective for Alpha Emitters by Application - Percentage Breakdown of Value Sales for Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications for the Years 2023 & 2030
  • EUROPE
    • Alpha Emitters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 22: Europe Recent Past, Current & Future Analysis for Alpha Emitters by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: Europe 8-Year Perspective for Alpha Emitters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 24: Europe Recent Past, Current & Future Analysis for Alpha Emitters by Application - Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 25: Europe 8-Year Perspective for Alpha Emitters by Application - Percentage Breakdown of Value Sales for Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications for the Years 2023 & 2030
  • FRANCE
    • Alpha Emitters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 26: France Recent Past, Current & Future Analysis for Alpha Emitters by Application - Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: France 8-Year Perspective for Alpha Emitters by Application - Percentage Breakdown of Value Sales for Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications for the Years 2023 & 2030
  • GERMANY
    • Alpha Emitters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 28: Germany Recent Past, Current & Future Analysis for Alpha Emitters by Application - Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Germany 8-Year Perspective for Alpha Emitters by Application - Percentage Breakdown of Value Sales for Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications for the Years 2023 & 2030
  • ITALY
    • TABLE 30: Italy Recent Past, Current & Future Analysis for Alpha Emitters by Application - Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Italy 8-Year Perspective for Alpha Emitters by Application - Percentage Breakdown of Value Sales for Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications for the Years 2023 & 2030
  • UNITED KINGDOM
    • Alpha Emitters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 32: UK Recent Past, Current & Future Analysis for Alpha Emitters by Application - Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: UK 8-Year Perspective for Alpha Emitters by Application - Percentage Breakdown of Value Sales for Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 34: Rest of Europe Recent Past, Current & Future Analysis for Alpha Emitters by Application - Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Rest of Europe 8-Year Perspective for Alpha Emitters by Application - Percentage Breakdown of Value Sales for Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Alpha Emitters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 36: Asia-Pacific Recent Past, Current & Future Analysis for Alpha Emitters by Application - Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Asia-Pacific 8-Year Perspective for Alpha Emitters by Application - Percentage Breakdown of Value Sales for Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 38: Rest of World Recent Past, Current & Future Analysis for Alpha Emitters by Application - Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Rest of World 8-Year Perspective for Alpha Emitters by Application - Percentage Breakdown of Value Sales for Bone Metastasis, Ovarian Cancer, Pancreatic Cancer, Melanoma and Other Applications for the Years 2023 & 2030

IV. COMPETITION

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!